rhamnose has been researched along with globotriaosylceramide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hong, H; Li, X; Liu, Z; Lu, Z; Pieters, RJ; Qin, X; Shi, J; Wu, Z; Zhou, Z | 1 |
1 other study(ies) available for rhamnose and globotriaosylceramide
| Article | Year |
|---|---|
Repurposing the Pentameric B-Subunit of Shiga Toxin for Gb3-Targeted Immunotherapy of Colorectal Cancer by Rhamnose Conjugation.
Topics: Animals; Antigens, Tumor-Associated, Carbohydrate; Colorectal Neoplasms; Haptens; Humans; Immunotherapy; Mice; Rhamnose; Shiga Toxin; Trihexosylceramides | 2022 |